The Effects of Antipsychotic Dose Reduction on Movement Disorders and Cardiometabolic Indices in Patients Remitted from a First Episode of Psychosis

AP-dose reduction modestly benefits AP-related Parkinsonism, weight gain, cholesterol levels and potentially tardive dyskinesia in patients after FEP over time. These benefits should be carefully weighed against the risks of relapse and suicide.

Authors

Institutions

Publication Details

Journal
Schizophrenia Bulletin
Published
2025-06-28
DOI
https://doi.org/10.1093/schbul/sbaf116
Primary Topic
Schizophrenia research and treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Effects of Antipsychotic Dose Reduction on Movement Disorders and Cardiometabolic Indices in Patients Remitted from a First Episode of Psychosis

Selene Veerman, Truus van den Brink, Anton B. P. Staring, Yinzhao Liu et al.
Schizophrenia Bulletin
Schizophrenia research and treatment
article

The Effects of Antipsychotic Dose Reduction on Movement Disorders and Cardiometabolic Indices in Patients Remitted from a First Episode of Psychosis

Selene Veerman, Truus van den Brink, Anton B. P. Staring, Yinzhao Liu, Gunnar Faber, Marieke Begemann, Martin D. de Jonge, Ellen Graveland, Matej Djordjevic, Machteld Marcelis, Thérèse van Amelsvoort, Jim van Os, Martijn Kikkert, Benjamin I. Perry, Erna van’t Hag, Nynke Boonstra, Albert Batalla, Iris E. Sommer, Simone Kamphuis, Sybren Wiersma, Shiral S. Gangadin, Joran Lokkerbol, Bodyl A. Brand, Sanne Koops, Natalie D. Veen, Joelle Hoornaar, Toon Anton Willem Scheurink, Koen P. Grootens, P. Roberto Bakker, Steven Berendsen, Karin Huizer, Filip Smit, Maarten Bak, J. Joris Hage, Jörg Kurkamp, Alban Voppel, Priscilla P. Oomen, Henderikus Knegtering, Ben F. M. Wijnen, Franciska de Beer, Bram‐Sieben Rosema, Wim Veling, Sinan Gülöksüz, Iris M. H. Hamers, Lieuwe de Haan, Nico van Beveren, Nico J.M. van Beveren, Gerdina Hendrika Maria Pijnenborg, Jort Noorman, Ruben Curfs, Inge Hobus
article en

Abstract

AP-dose reduction modestly benefits AP-related Parkinsonism, weight gain, cholesterol levels and potentially tardive dyskinesia in patients after FEP over time. These benefits should be carefully weighed against the risks of relapse and suicide.

Schizophrenia Bulletin
University Medical Center Groningen (NL), Maastricht University Medical Centre (NL), Erasmus MC (NL), Maastricht University (NL), Parnassia Groep (NL), Arkin (NL), Reinier van Arkel (NL), University of Birmingham (GB), Erasmus University Rotterdam (NL)
ZonMw
Openalex Percentile: Top 74%
Schizophrenia research and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.